*** CHEMICAL IDENTIFICATION *** RTECS NUMBER : AR9100000 CHEMICAL NAME : Acridine, 9-(p-dimethylaminoanilino)- CAS REGISTRY NUMBER : 13365-38-3 BEILSTEIN REFERENCE NO. : 0487364 LAST UPDATED : 199612 DATA ITEMS CITED : 7 MOLECULAR FORMULA : C21-H19-N3 MOLECULAR WEIGHT : 313.43 WISWESSER LINE NOTATION : T C666 BNJ IMR DN1&1 COMPOUND DESCRIPTOR : Drug Mutagen SYNONYMS/TRADE NAMES : * Acridine, 9-((p-(dimethylamino)phenyl)amino)- * N'-9-Acridinyl-N,N-dimethyl-1,4-benzenediamine * 1,4-Benzenediamine, N'-9-acridinyl-N,N-dimethyl- * 9-(p-Dimethylaminoanilino)acridine * 9-((p-(Dimethylamino)phenyl)amino)acridine * NSC 13002 * WIN 1701 *** HEALTH HAZARD DATA *** ** ACUTE TOXICITY DATA ** TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 15 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NCIAL* Progress Report Submitted to the National Cancer Institute by Arthur D. Little, Inc. (15 Acorn Park, Cambridge, MA 02140) Volume(issue)/page/year: -,326,1967 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 80970 ug/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986 TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 5 mg/kg TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Gastrointestinal - changes in structure or function of salivary glands REFERENCE : NCIAL* Progress Report Submitted to the National Cancer Institute by Arthur D. Little, Inc. (15 Acorn Park, Cambridge, MA 02140) Volume(issue)/page/year: -,326,1967 TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Primate - monkey DOSE/DURATION : 5 mg/kg TOXIC EFFECTS : Sense Organs and Special Senses (Eye) - mydriasis (pupillary dilation) Behavioral - convulsions or effect on seizure threshold Cardiac - pulse rate REFERENCE : NCIAL* Progress Report Submitted to the National Cancer Institute by Arthur D. Little, Inc. (15 Acorn Park, Cambridge, MA 02140) Volume(issue)/page/year: -,326,1967 ** OTHER MULTIPLE DOSE TOXICITY DATA ** TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 35 mg/kg/28D-I TOXIC EFFECTS : Cardiac - arrhythmias (including changes in conduction) Lungs, Thorax, or Respiration - fibrosis, focal (pneumoconiosis) Gastrointestinal - changes in structure or function of salivary glands REFERENCE : NCIAL* Progress Report Submitted to the National Cancer Institute by Arthur D. Little, Inc. (15 Acorn Park, Cambridge, MA 02140) Volume(issue)/page/year: -,326,1967 TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Primate - monkey DOSE/DURATION : 35 mg/kg/28D-I TOXIC EFFECTS : Lungs, Thorax, or Respiration - fibrosis, focal (pneumoconiosis) Gastrointestinal - changes in structure or function of salivary glands Blood - pigmented or nucleated red blood cells REFERENCE : NCIAL* Progress Report Submitted to the National Cancer Institute by Arthur D. Little, Inc. (15 Acorn Park, Cambridge, MA 02140) Volume(issue)/page/year: -,326,1967 ** MUTATION DATA ** TYPE OF TEST : DNA damage TEST SYSTEM : Mammal - species unspecified Lymphocyte DOSE/DURATION : 2 umol/L REFERENCE : JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 24,170,1981 *** END OF RECORD ***